#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Demyelination Guillain-Barre syndrome Frontotemporal dementia Paget's disease of the vulva Rhabdomyosarcoma recurrent Congenital generalised lipodystrophy Thrombotic thrombocytopenic purpura Immunodeficiency congenital Peripheral primitive neuroectodermal tumour of soft tissue Scleroderma associated digital ulcer Synovial sarcoma metastatic Multiple system atrophy Neovascular age-related macular degeneration Choroidal dystrophy Ocular myasthenia More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous Haemolytic uraemic syndrome – Diagnostics IgA nephropathy – Treatment Gaucher’s disease type I – Basic Information Atypical haemolytic uraemic syndrome Hereditary motor and sensory neuropathy – Diagnostics Adrenogenital syndrome Anaplastic thyroid cancer – Trials in Disease Marginal zone lymphoma refractory – Life with Disease Ewing’s sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Staphylococcus Aureus Darbepoetin Alfa Mps-102 Phenylalanine Xevinapant Rmc-035 Ammonium Chloride Bp SALICYLIC ACID Doxribtimine Exidavnemab IHMA-2121771-2 Benserazide Hydrochloride Macitentan Betamethasone Sodium Phosphate AZD6234 Methyl Aminolevulinate Tegoprubart Roxadustat Capecitabine Oteracil More therapies…

    Learn about Your Condition

    Rhabdoid tumour of the kidney High-grade B-cell lymphoma Aplastic anaemia Cardiac sarcoidosis Hairy cell leukaemia Nephroblastoma Hypertonic bladder Infant sedation Sickle cell anaemia Follicular lymphoma Pyoderma gangrenosum Procedural anxiety Catatonia Partial seizures Primary adrenal insufficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dilated cardiomyopathy

  • A Study of Danicamtiv for Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy to Test if it Improves Heart Function and Exercise Ability

    Recruiting

    4 1
    Investigated Diseases:
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Danicamtiv
    Belgium Denmark France Hungary Italy The Netherlands +3

  • Study of Risedronate Sodium for Patients with Dilated Cardiomyopathy Due to Troponin T Gene Mutation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Risedronate Sodium
    Spain

  • Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Candesartan Cilexetil
    The Netherlands Spain

  • Study on Anakinra for Treating Inflammatory Dilated Cardiomyopathy in Patients: Evaluating Efficacy and Safety of Anakinra with Standard Care vs. Standard Care Alone

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Anakinra
    Italy

  • Study on Early Use of Ivabradine for Children with Heart Failure Due to Dilated Cardiomyopathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac failure acute
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Ivabradine Hydrochloride
    Italy

  • Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

    Not recruiting

    2 1
    Investigated Drugs:
    • Ab-1002
    Austria Belgium Bulgaria Germany Hungary The Netherlands +3
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!